The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...
Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...
For the first time, CMS has released negotiated prices for high-cost drugs covered under both Medicare Part D and Part B, ...
The Centers for Medicare & Medicaid Services (CMS) announced that Botox is among 15 prescription drugs newly added to the ...
The selected medications treat a range of conditions, including cancer, psoriatic arthritis, and human immunodeficiency virus ...
A recent U.S. Court of Appeals for the Third Circuit ruling upholding the federal Inflation Reduction Act (IRA)’s drug price ...
As the Trump administration begins to make its mark on the Medicare drug price negotiation program and pursue its own policies on prescription drugs, litigation over program continues. In the two ...
President Donald Trump’s approach to lowering drug prices has leaned heavily on executive orders and voluntary deals with drugmakers, rather than legislation. (Andrew Harnik / Getty Images) As ...
On May 12, 2025, the Centers for Medicare & Medicaid Services (CMS) issued draft guidance for the third cycle of the IRA’s Medicare Drug Price Negotiation Program (Negotiation Program). This draft ...
A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ challenges to the Inflation Reduction Act of 2022's (IRA) Medicare Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results